Why Inovio Pharmaceuticals INO is trading below its true worth Overhead Buying 20260508 RARE Ultragenyx Pharmaceutical revenue surges 20 on new drug demand but wider losses disappoint investors ANGI Angi Inc notches 148 percent Q4 2025 EPS beat shares gain 179 percent in todays trading